Active Pharmaceutical Ingrediants | |||||
---|---|---|---|---|---|
S.No. | Name of the Product | CAS No | Segment | STATUS | Therapeutic area |
1 | Citicoline Sodium | 33818-15-4 | GENERICS | Developed | Alzheimer's disease and dementia in Parkinson's disease |
2 | Oxcarbazepine | 28721-07-5 | GENERICS | Developed | Anticonvulsant |
3 | Riluzole | 1744-22-5 | GENERICS | Developed | Lou Gehrig's disease |
4 | Oseltamivir Phosphate | 204255-11-8 | GENERICS | Developed | Neuraminidase inhibitors |
5 | Etodolac | 41340-25-4 | GENERICS | Developed | Antiinflammatory |
6 | Tenofovir Disoproxil Fumarate | 202138-50-9 | GENERICS | Developed | Human immunodeficiency virus (HIV) |
7 | Linagliptin | 668270-12-0 | GENERICS | Developed | Type 2 diabetes |
8 | Etoricoxib | 202409-33-4 | GENERICS | Developed | Antiinflammatory |
9 | Duloxetine HCl | 136434-34-9 | GENERICS | Developed | Depression and Anxiety |
10 | Atorvastatin | 134523-00-5 | GENERICS | Developed | HMG-CoA reductase inhibitors, or statins |
11 | Darunavir | 206361-99-1 | GENERICS | Developed | Protease inhibitors |
12 | Raltegravir Potassium | 518048-05-0 | GENERICS | Developed | Human immunodeficiency virus (HIV) |
13 | Bakuchiol | 10309-37-2 | Natural | Developed | Natural product (Skin care) |
14 | Donepezil Hydrochloride | 120011-70-3 | GENERICS | Tech Capability | Alzheimer's disease |
15 | Apixaban | 503612-47-3 | GENERICS | Tech Capability | Anticoagulant |
16 | Dabigatran Etexilate Mesylate | 872728-81-9 | GENERICS | Tech Capability | Anticoagulant |
17 | Rivaroxaban | 366789-02-8 | GENERICS | Tech Capability | Anticoagulant |
18 | Vortioxetine Hydrobromide | 960203-27-4 | GENERICS | Tech Capability | Antidepressant |
19 | Bisoprolol fumarate | 104344-23-2 | GENERICS | Tech Capability | Antihypertension |
20 | Dexlansoprazole | 138530-94-6 | GENERICS | Tech Capability | Gastroesophageal reflux disease |
21 | Atazanavir sulphate | 229975-97-7 | GENERICS | Tech Capability | Human immunodeficiency virus (HIV) |
22 | Ritonavir | 155213-67-5 | GENERICS | Tech Capability | Human immunodeficiency virus (HIV) |
23 | Tetrabenazine | 58-46-8 | GENERICS | Tech Capability | Hyperkinetic movement disorders |
24 | Azilsartan Kamedoxomil | 863031-24-7 | GENERICS | Tech Capability | Hypertension |
25 | Varenicline | 375815-87-5 | GENERICS | Tech Capability | Nicotine addiction |
26 | Deferasirox | 201530-41-8 | GENERICS | Tech Capability | Oral iron chelator |
27 | Apremilast | 608141-41-9 | GENERICS | Tech Capability | Psoriatic arthritis |
28 | Lurasidone Hydrochloride | 367514-88-3 | GENERICS | Tech Capability | Schizophrenia (Antipsychotics) |
29 | Cinacalcet Hydrochloride | 364782-34-3 | GENERICS | Tech Capability | Secondary hyperparathyroidism |
30 | Armodafinil | 68693-11-8 | GENERICS | Tech Capability | Sleeping disorder |
31 | Dapagliflozin | 461432-26-8 | GENERICS | Tech Capability | Type 2 diabetes |
32 | Empagliflozin | 864070-44-0 | GENERICS | Tech Capability | Type 2 diabetes |